The trained AI model correctly detected 98 and 100% of body parts and eczema areas, respectively; across 220 test images. HealthDay News — An artificial intelligence (AI) 3-Item Severity (3IS) score ...

To assess the safety and efficacy of IV ibuprofen in older adults, researchers conducted a post hoc subgroup analysis with data from 4 prospective clinical studies.

In a recent interview on NBC News’ "Meet the Press," Murthy said Congress has failed to act on what he described as a growing crisis.

ND0612 is an investigational drug-device therapy that provides a 24-hour continuous subcutaneous infusion of levodopa/carbidopa solution. The Food and Drug Administration (FDA) has accepted for review ...

“The FDA’s decision to grant Fast Track designation for TEV-53408, an investigational anti-IL-15 antibody therapy, reflects the promising nature of the treatment and the urgent unmet need of people ...

Findings seen for patients with extensive-stage small cell lung cancer, following standard induction therapy.

The Food and Drug Administration (FDA) has accepted for Priority Review the Biologics License Application (BLA) for sibeprenlimab for the treatment of immunoglobulin A nephropathy (IgAN) in adults.

Prothena has made the decision to discontinue the AFFIRM-AL trial, including the open-label extension portion.

The protest happened roughly 27 minutes into the meeting, held at NIH headquarters in Bethesda, Md. In a video obtained by CNN, Bhattacharya is shown telling staff that, based on his review of ...

The approval for interchangeability was supported by data from a phase 4 trial that assessed the pharmacokinetics, efficacy, safety, and immunogenicity of Hadlima vs Humira in patients with moderate ...

The researchers found that after 64 weeks, participants had a mean weight loss of −16.7%, with a mean semaglutide dose of 1.08mg/week.

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic retinopathy who have previously responded to at least 2 intravitreal ...